Cello Health PLC (LON:CLL)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as low as $126.50. Cello Health shares last traded at $128.00, with a volume of 71,599 shares.
Separately, FinnCap reiterated a “corporate” rating on shares of Cello Health in a report on Thursday, July 18th.
The firm has a market cap of $135.79 million and a P/E ratio of 20.98. The firm has a fifty day simple moving average of GBX 122.47. The company has a debt-to-equity ratio of 4.70, a quick ratio of 1.23 and a current ratio of 1.28.
In other news, insider Mark Bentley sold 129,800 shares of Cello Health stock in a transaction on Thursday, June 20th. The shares were sold at an average price of GBX 127 ($1.66), for a total transaction of £164,846 ($215,400.50).
About Cello Health (LON:CLL)
Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients.
Recommended Story: The Discount Rate – What You Need to Know
Receive News & Ratings for Cello Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Health and related companies with MarketBeat.com's FREE daily email newsletter.